| Code | Headline | Release Date |
|---|---|---|
IQGPrice Sensitive |
40060 NSX Removal from Official List - Company Removed from Official List - Failure to pay Annual Listing Fee - 2022/2023 - Delisted 19th of September 2022 Company Removed from Official List - Failure to pay Annual Listing Fee - 2022/2023 - Delisted 19th of September 2022 |
19-Sep-2022 10:05:56 AM |
IQGPrice Sensitive |
40050 NSX Suspension from Official Quotation - Continued Suspensison - Failure to lodge Preliminary Final Report for 30 June 2022 Continued Suspensison - Failure to lodge Preliminary Final Report for 30 June 2022 |
14-Sep-2022 10:14:18 AM |
IQGPrice Sensitive |
40050 NSX Suspension from Official Quotation - Continued Suspension - Non-payment of Annual Listing Fee 2022-2023 Continued Suspension - Non-payment of Annual Listing Fee 2022-2023 |
15-Aug-2022 10:00:54 AM |
IQGPrice Sensitive |
41999 NSX General Market Disclosure Other - Execution Of Deed Of Company Arrangement Execution Of Deed Of Company Arrangement |
05-Aug-2022 4:41:14 PM |
IQGPrice Sensitive |
41999 NSX General Market Disclosure Other - Outcome Of Creditors' Meeting Outcome Of Creditors' Meeting |
01-Aug-2022 3:36:21 PM |
IQGPrice Sensitive |
40050 NSX Suspension from Official Quotation - Deferral Financial Reporting Obligations Deferral Financial Reporting Obligations |
17-May-2022 10:16:33 AM |
IQGPrice Sensitive |
40050 NSX Suspension from Official Quotation - Continued Suspension - Failure to lodge Half Yearly Financial Statements- 31 December 2021 Continued Suspension - Failure to lodge Half Yearly Financial Statements- 31 December 20211 |
17-Mar-2022 10:06:41 AM |
IQGPrice Sensitive |
40050 NSX Suspension from Official Quotation - The phone number for the VA has now been corrected The phone number for the Voluntary Administrator was incorrect and nothing else has changed. |
16-Mar-2022 8:09:14 AM |
IQGPrice Sensitive |
40050 NSX Suspension from Official Quotation - iQG Seeks Voluntary Admin Today to Restructure The iQ Group Global Ltd seeks Voluntary Administration today to restructure |
11-Mar-2022 8:50:44 AM |
IQGPrice Sensitive |
41999 NSX General Market Disclosure Other - Worldwide license for Harvard Uni’s eRapid Technology Antisoma Therapeutics secures worldwide license for Harvard University’s eRapid technology for at-home diagnostic testing |
07-Mar-2022 10:30:32 AM |
IQG |
40814 NSX Company Secretary Appointment/Resignation - Appointment/Resignation of Company Secretary Appointment/Resignation of Company Secretary |
13-Dec-2021 4:48:35 PM |
IQGPrice Sensitive |
41999 NSX General Market Disclosure Other - FDA Breakthrough Devices Designation FDA Breakthrough Devices Designation application to fast track rapid saliva glucose testing |
13-Dec-2021 10:10:45 AM |
IQG |
40930 NSX Results of Meeting - IQG Results of AGM FY2021 IQG Results of AGM FY2021 |
19-Nov-2021 12:31:07 PM |
IQG |
40516 NSX Chairman's Address - IQG Chairman's Address IQG Chairman's Address to Shareholders AGM: 19 November 2021 |
18-Nov-2021 4:50:10 PM |
IQGPrice Sensitive |
41999 NSX General Market Disclosure Other - Wyss Validation Study SARS-CoV-2 Wyss Validation Study SARS-CoV-2 |
11-Nov-2021 9:06:05 AM |
IQGPrice Sensitive |
41999 NSX General Market Disclosure Other - OncoTEX Gold Compound Licensing Gold Technology for Immune Response Cancer Therapy Licensed to OncoTEX |
05-Nov-2021 9:06:13 AM |
IQG |
41999 NSX General Market Disclosure Other - Jobkeeper s323DB Notice Jobkeeper s323DB Notice |
02-Nov-2021 2:30:49 PM |
IQG |
40910 NSX Notice of Annual General Meeting - Notice of Annual General Meeting & Proxy Form Notice of Annual General Meeting & Proxy Form |
20-Oct-2021 8:52:08 AM |
IQGPrice Sensitive |
41999 NSX General Market Disclosure Other - LSBD Update on Biosensor FDA Pre-Submission Filed a Pre-Submission package with the United States (US) Food and Drug Administration (FDA). |
19-Oct-2021 9:29:08 AM |
IQGPrice Sensitive |
40599 NSX Periodic Disclosure Other - Additional Annual Report Disclosure Comparative table of the P&L and of the assets and liabilities of the group for the last 5 financial years. |
06-Oct-2021 2:55:28 PM |
IQG |
40023 NSX Director's Declaration & Undertaking - Director's Declaration - Peter Mercouris Director's Declaration - Peter Mercouris |
27-Sep-2021 4:34:55 PM |
IQGPrice Sensitive |
40510 NSX Annual Report - Annual Report 2021 Annual Report for the year ended June 2021 |
13-Sep-2021 4:05:38 PM |
IQG |
40024 NSX Nominated Adviser's Declaration - Annual Nominated Adviser Statement - 2021-2022 Annual Nominated Adviser Statement - 2021-2022 |
23-Aug-2021 3:25:34 PM |
IQGPrice Sensitive |
40099 NSX Official List Other - Portfolio Company Awarded $6.3M Federal Govt Grant GBS awarded $6.3 million Federal Government science grant to manufacture biosensor technology. |
09-Jul-2021 9:27:06 AM |
IQG |
40814 NSX Company Secretary Appointment/Resignation - Appointment / Resignation of Company Secretary IQG Appointment / Resignation of Company Secretary |
04-May-2021 11:25:25 AM |
IQG |
41999 NSX General Market Disclosure Other - Progress of clinical programs Progress of clinical programs by its subsidiary companies; Life Science Biosensor Diagnostics Pty Ltd and OncoTex Inc. |
29-Apr-2021 3:20:41 PM |
IQGPrice Sensitive |
41999 NSX General Market Disclosure Other - Proceedings brought against ADS Capital Pty Ltd Proceedings brought against ADS Capital Pty Ltd and Anthony Di Pizio |
08-Apr-2021 4:08:07 PM |
IQG |
40140 NSX Section 205G Notice Initial/Final Director's Interests - Directors Initial Interests Peter Mercouris Directors Initial Interests Peter Mercouris |
22-Mar-2021 3:55:14 PM |
IQG |
40810 NSX Director Appointment/Resignation - Appointment of Director Peter Mercouris Appointment of Director - Peter Mercouris |
22-Mar-2021 3:55:10 PM |
IQGPrice Sensitive |
40540 NSX Half Yearly Report - iQG Limited Half-yearly Financial Report iQG Limited Half-yearly Financial Report |
12-Mar-2021 4:06:45 PM |
IQG |
40120 NSX Change in Substantial Shareholder - Form 604 Con Tsigounis Change in Substantial Holdings Form 604 Con Tsigounis |
22-Feb-2021 9:51:09 AM |
IQG |
40120 NSX Change in Substantial Shareholder - Form 604 George Syrmalis Change in Substantial Holdings Form 604 George Syrmalis |
22-Feb-2021 9:50:19 AM |
IQG |
40150 NSX Section 205G Notice Change in Director's Interests - Change of Director’s Interest Con Tsigounis Change of Director’s Interest Con Tsigounis |
22-Feb-2021 9:48:40 AM |
IQG |
40150 NSX Section 205G Notice Change in Director's Interests - Change of Director’s Interest George Syrmalis Change of Director’s Interest George Syrmalis |
22-Feb-2021 9:44:53 AM |
IQG |
40517 NSX Letter to Shareholder's - Disregard Change of Directors Interest Disregard Notice of 5 February 2021 |
08-Feb-2021 3:39:28 PM |
IQG |
41999 NSX General Market Disclosure Other - iQG Employee Share Plan Issue iQG Employee Share Plan Issue Approved |
08-Feb-2021 3:26:55 PM |
IQG |
40150 NSX Section 205G Notice Change in Director's Interests - Change of Director’s Interest George Syrmalis Change of Director’s Interest George Syrmalis |
05-Feb-2021 2:07:49 PM |
IQG |
40829 NSX Appointment/Resignation Other - iQG Change of Auditor Change of Auditor |
01-Feb-2021 11:24:03 AM |
IQG |
40930 NSX Results of Meeting - iQG Limited Results of AGM iQG Results of AGM |
29-Jan-2021 3:22:54 PM |
IQG |
40516 NSX Chairman's Address - iQG Chairmans Address iQG Chairman's Address to Shareholders AGM 29 January 2021 |
28-Jan-2021 4:48:39 PM |
IQG |
40814 NSX Company Secretary Appointment/Resignation - iQG Limited Appointment/Resignation of CoSec iQG Limited Appointment/Resignation of Company Secretary 12 January 2021 |
12-Jan-2021 3:02:42 PM |
IQGPrice Sensitive |
40081 NSX Response to Query - Response to NSX Price Query Response to NSX Price Query |
12-Jan-2021 10:15:31 AM |
IQGPrice Sensitive |
40080 NSX Query - Price Query Price Query |
12-Jan-2021 10:15:27 AM |
IQG |
40910 NSX Notice of Annual General Meeting - Notice of Annual General Meeting & Proxy Form Notice of Annual General Meeting & Proxy Form |
24-Dec-2020 11:30:25 AM |
IQG |
40031 NSX Trading Halt Status - Removal of Trading Halt Removal of Trading Halt |
02-Dec-2020 10:15:41 AM |
IQGPrice Sensitive |
40030 NSX Trading Halt - Request Trading Halt Request for Trading Halt Regarding License with Wyss Institute at Harvard University |
01-Dec-2020 11:07:24 AM |
IQG |
40999 NSX Notice of Meeting Other - Postponement of Annual General Meeting Postponement of Annual General Meeting |
25-Nov-2020 12:28:52 PM |
IQGPrice Sensitive |
41999 NSX General Market Disclosure Other - Media Report Media report in relation to Disrupt litigation |
23-Nov-2020 4:06:26 PM |
IQGPrice Sensitive |
40081 NSX Response to Query - Response to Periodic Disclosure Query Response to Periodic Disclosure Query |
05-Nov-2020 5:02:11 PM |
IQGPrice Sensitive |
40080 NSX Query - Periodic Disclosure Query Periodic Disclosure Query |
05-Nov-2020 4:58:23 PM |
IQGPrice Sensitive |
40510 NSX Annual Report - Annual Report to the Shareholders Annual Report to the Shareholders |
26-Oct-2020 8:09:19 AM |
IQG |
40910 NSX Notice of Annual General Meeting - Notice of Annual General Meeting & Proxy Form Notice of Annual General Meeting & Proxy Form |
26-Oct-2020 8:09:16 AM |
IQGPrice Sensitive |
40510 NSX Annual Report - Annual Report 2020 Annual Report for the year ended 30 June 2020 |
12-Sep-2020 6:22:21 PM |
IQG |
41999 NSX General Market Disclosure Other - Change in Auditor Entity Change in Auditor Entity |
22-Jul-2020 7:32:30 AM |
IQGPrice Sensitive |
41999 NSX General Market Disclosure Other - COVID-19 Diagnostic Test With Harvard University COVID-19 Diagnostic Test Collaboration with Wyss Institute for Biology Inspired Engineering, Harvard University |
29-May-2020 11:11:23 AM |
IQGPrice Sensitive |
41999 NSX General Market Disclosure Other - FDA Engagement Commences for Saliva Glucose Biosensor Market announcement – Life Science Biosensor Diagnostics Pty Ltd (LSBD) commences FDA engagement for Saliva Glucose Biosensor Diagnostic Test. |
05-May-2020 9:26:10 AM |
IQGPrice Sensitive |
40540 NSX Half Yearly Report - IQN Half Yearly Report 31 December 2019 IQG Half Yearly Report 31 December 2019 |
16-Mar-2020 9:03:12 AM |
IQG |
40770 NSX Trading Code Change Notification - Change of Trading Code to IQG - Effective from Monday, 9th of March 2020. Change of Trading Code to IQG - Effective from Monday, 9th of March 2020. |
02-Mar-2020 4:05:46 PM |
IQG |
40760 NSX Company Name Change Notification - Change of Company Name Change of Company Name |
28-Nov-2019 4:31:28 PM |
IQG |
40930 NSX Results of Meeting - Results of Annual General Meeting Results of Annual General Meeting |
26-Nov-2019 9:06:55 AM |
IQG |
40910 NSX Notice of Annual General Meeting - Notice of Annual General Meeting & Proxy Form Notice of Annual General Meeting & Proxy Form |
25-Oct-2019 3:52:56 PM |
IQGPrice Sensitive |
40510 NSX Annual Report - 2019 Annual Report 2019 Annual Report |
01-Oct-2019 7:18:09 AM |
IQGPrice Sensitive |
41999 NSX General Market Disclosure Other - IQN acquires interest in new anticancer drug platform IQNovate acquires interest in a new anticancer drug platform from University of Texas |
18-Sep-2019 7:08:54 AM |
IQGPrice Sensitive |
40530 NSX Preliminary/Final Statement - 30 June 2019 Preliminary Financial Statements 30 June 2019 Preliminary Financial Statements |
16-Sep-2019 9:33:09 AM |
IQG |
41999 NSX General Market Disclosure Other - Change of Auditor Notice of change of auditor from RSM Australia Partners to BDO East Coast Partnership |
23-Jul-2019 8:49:19 AM |
IQGPrice Sensitive |
41999 NSX General Market Disclosure Other - Update on Timetable Update on Timetable for IQN's Scheme of Arrangement |
18-Apr-2019 11:15:01 AM |
IQGPrice Sensitive |
40540 NSX Half Yearly Report - IQNovate Half Yearly Report IQNovate Half Yearly Report for 6 months to 31 December 2018 |
18-Mar-2019 7:49:30 AM |
IQGPrice Sensitive |
40081 NSX Response to Query - Response to Price Query Response to Price Query |
12-Dec-2018 7:10:56 AM |
IQGPrice Sensitive |
40080 NSX Query - Price Query Price Query |
12-Dec-2018 7:10:40 AM |
IQGPrice Sensitive |
41999 NSX General Market Disclosure Other - General Market Disclosure iQnovate subsidiary qualified by US regulator to undertake capital raise and applies to list on Nasdaq Stock Exchange |
28-Nov-2018 10:47:38 AM |
IQG |
40930 NSX Results of Meeting - Results of Meeting Results of 2018 AGM |
27-Nov-2018 9:11:49 AM |
IQG |
40516 NSX Chairman's Address - Chairman's Address Chairman's Address |
26-Nov-2018 9:43:54 AM |
IQG |
41999 NSX General Market Disclosure Other - Update to Scheme Implementation Dates Update to Scheme Implementation Dates |
19-Nov-2018 12:43:13 PM |
IQG |
40910 NSX Notice of Annual General Meeting - Notice of 2018 AGM Notice of 2018 AGM |
26-Oct-2018 5:00:21 PM |
IQGPrice Sensitive |
40510 NSX Annual Report - 2018 Annual Report 2018 Annual Report |
30-Sep-2018 5:10:38 PM |
IQG |
40399 NSX Issued Capital Other - Application for Securities Application for Quotation of Additional Securities |
20-Sep-2018 4:57:28 PM |
IQGPrice Sensitive |
40315 NSX Placement - Private Placement Private Placement |
19-Sep-2018 11:01:50 AM |
IQGPrice Sensitive |
40530 NSX Preliminary/Final Statement - 2018 Preliminary Final Results & Financial Statements 2018 Preliminary Final Results & Financial Statements |
14-Sep-2018 7:02:11 AM |
IQG |
41999 NSX General Market Disclosure Other - Application For Quotation of New Securities Application For Quotation of New Securities |
13-Aug-2018 7:32:10 PM |
IQGPrice Sensitive |
40315 NSX Placement - Private Placement Private Placement of Ordinary Shares & Cleansing Statement |
06-Aug-2018 1:08:39 PM |
IQGPrice Sensitive |
41999 NSX General Market Disclosure Other - IQNOVATE LTD INTENDS TO RE-DOMICILE TO USA IQNOVATE LTD ANNOUNCES INTENTION TO RE-DOMICILE TO THE UNITED STATES AND LIST ON NASDAQ |
01-Aug-2018 9:58:29 AM |
IQGPrice Sensitive |
41999 NSX General Market Disclosure Other - Chinese Patent Granted for Biosensor Platform Chinese Patent Granted for Biosensor Platform |
02-Jul-2018 4:18:34 PM |
IQGPrice Sensitive |
41999 NSX General Market Disclosure Other - Application for Quotation of Additional Securities Application for Quotation of Additional Securities |
12-Jun-2018 8:08:35 AM |
IQGPrice Sensitive |
40315 NSX Placement - Private Placement Private Placement of iQnovate Ltd Shares |
12-Jun-2018 8:07:35 AM |
IQGPrice Sensitive |
41999 NSX General Market Disclosure Other - Update on Saliva Glucose Biosensor & BioSensX Update on Saliva Glucose Biosensor & BioSensX Digital Point of Care Diagnostics |
06-Jun-2018 3:00:38 PM |
IQG |
40399 NSX Issued Capital Other - Application for Quotation of New Securities Application for Quotation of New Securities |
29-Mar-2018 2:21:50 PM |
IQG |
40120 NSX Change in Substantial Shareholder - Change in Substantial Shareholder Change in Substantial Shareholder |
29-Mar-2018 1:53:13 PM |
IQG |
40120 NSX Change in Substantial Shareholder - Change in Substantial Shareholder Change in Substantial Shareholder |
29-Mar-2018 12:52:30 PM |
IQG |
40150 NSX Section 205G Notice Change in Director's Interests - Change in Directors' Interests Change in Directors' Interests |
29-Mar-2018 10:45:05 AM |
IQGPrice Sensitive |
40550 NSX Half Yearly Report Audit Review - Half Yearly Accounts 31 December Financial Statements |
16-Mar-2018 2:32:25 PM |
IQG |
41999 NSX General Market Disclosure Other - Change of Address Relocating to New Corporate Headquarters |
01-Mar-2018 11:58:58 AM |
IQG |
41999 NSX General Market Disclosure Other - Supplementary Trading Policy Supplementary Trading Policy |
19-Feb-2018 4:19:03 PM |
IQGPrice Sensitive |
40081 NSX Response to Query - Response to Query - Convertible Note Issue Response to Query - Convertible Note Issue |
19-Feb-2018 4:18:20 PM |
IQGPrice Sensitive |
40080 NSX Query - Query - Convertible Note Issue Query - Convertible Note Issue |
19-Feb-2018 4:17:48 PM |
IQG |
41999 NSX General Market Disclosure Other - Application for Quotation of Additional Securities Application for Quotation of Additional Securities |
31-Jan-2018 3:17:13 PM |
IQGPrice Sensitive |
40335 NSX Alteration to Issued Capital - Share Allotment & Cleansing Notice Share Allotment & Cleansing Notice |
31-Jan-2018 2:52:01 PM |
IQGPrice Sensitive |
40081 NSX Response to Query - Response to NSX Price Query Response to Price Query |
27-Dec-2017 9:57:42 AM |
IQGPrice Sensitive |
40080 NSX Query - NSX Price Query Price Query |
27-Dec-2017 9:57:36 AM |
IQG |
41999 NSX General Market Disclosure Other - Closure of Convertible Note Issue Closure of Convertible Note Issue |
22-Dec-2017 12:35:13 PM |
IQG |
40599 NSX Periodic Disclosure Other - Results from 2017 AGM Results from 2017 AGM |
27-Nov-2017 2:26:28 PM |
IQG |
40516 NSX Chairman's Address - 2017 Annual General Meeting Chairman's Address 2017 Annual General Meeting Chairman's Address |
27-Nov-2017 9:34:45 AM |
IQG |
41999 NSX General Market Disclosure Other - Extension of Convertible Note Issue Extension of Convertible Note Issue |
22-Nov-2017 6:42:24 PM |
IQG |
40910 NSX Notice of Annual General Meeting - Notice of 2017 Annual General Meeting Notice of 2017 Annual General Meeting |
27-Oct-2017 2:36:24 PM |
IQGPrice Sensitive |
40510 NSX Annual Report - 2017 Annual Report 2017 Annual Report |
20-Oct-2017 2:42:15 PM |
IQGPrice Sensitive |
40799 NSX Details Other - New License Agreement for MENA Region New License Agreement Signed for the MENA Region |
05-Oct-2017 11:03:30 AM |
IQGPrice Sensitive |
40530 NSX Preliminary/Final Statement - IQN Preliminary Final Report and Financials for 30 June 2017 IQNovate Preliminary Final Report and Financials for 30 June 2017 |
13-Sep-2017 8:10:49 PM |
IQG |
41999 NSX General Market Disclosure Other - Change of Company Auditor Change of Company Auditor |
31-Aug-2017 7:14:09 AM |
IQG |
40081 NSX Response to Query - Response to Price Query Response to Price Query |
07-Aug-2017 8:58:22 AM |
IQG |
40080 NSX Query - Price Query - 3rd of August 2017 Price Query - 3rd of August 2017 |
07-Aug-2017 8:58:09 AM |
IQG |
41999 NSX General Market Disclosure Other - Extension of Proposed Convertible Note Issue Extension of Proposed Convertible Note Issue |
05-Jul-2017 4:47:56 PM |
IQGPrice Sensitive |
40540 NSX Half Yearly Report - 31 December 2016 Half Yearly Report 31 December 2016 Half Yearly Report |
16-Mar-2017 4:42:07 PM |
IQG |
41999 NSX General Market Disclosure Other - Extension to Convertible Note Private Placement Extension to Convertible Note Private Placement |
07-Mar-2017 4:28:26 PM |
IQG |
40930 NSX Results of Meeting - Results of 2016 Annual General Meeting Results of 2016 Annual General Meeting |
18-Nov-2016 2:16:03 PM |
IQG |
40031 NSX Trading Halt Status - Removal of Trading Halt - Company to commence trading at 10.30am Removal of Trading Halt - Company to commence trading at 10.30am |
18-Nov-2016 10:14:34 AM |
IQGPrice Sensitive |
41999 NSX General Market Disclosure Other - Glucose Biosensor Systems (Greater China) Glucose Biosensor Systems (Greater China) and General Update |
18-Nov-2016 10:02:27 AM |
IQG |
40030 NSX Trading Halt - iQNovate Requests Trading Halt iQNovate Requests Trading Halt Pending Announcement |
17-Nov-2016 9:22:01 AM |
IQG |
40910 NSX Notice of Annual General Meeting - iQnovate Notice of 2016 AGM iQnovate Notice of 2016 AGM |
17-Oct-2016 4:10:48 PM |
IQG |
40365 NSX Extension of Offer - Share Placement Extended IQN Share Placement Extended |
10-Oct-2016 1:27:32 PM |
IQG |
40510 NSX Annual Report - 2016 Annual Report 2016 Annual Report |
13-Sep-2016 3:51:43 PM |
IQG |
40814 NSX Company Secretary Appointment/Resignation - Change of Company Secretary Change of Company Secretary |
22-Aug-2016 3:29:22 PM |
IQG |
40599 NSX Periodic Disclosure Other - Nominated Advisers Annual Statement to NSX Nominated Advisers Annual Statement to NSX |
21-Jul-2016 10:20:38 AM |
IQG |
40310 NSX Bonus Issue - Application for Quotation of Addition Securities - Reorganisation of Capital Application for Quotation of Addition Securities - Reorganisation of Capital |
13-Jul-2016 10:53:51 AM |
IQG |
40930 NSX Results of Meeting - Results of Extraordinary General Meeting Results of Extraordinary General Meeting |
05-Jul-2016 2:18:05 PM |
IQG |
40335 NSX Alteration to Issued Capital - Indicative Timetable for Proposed Share Split Indicative Timetable for Proposed Share Split |
01-Jul-2016 2:35:44 PM |
IQGPrice Sensitive |
41999 NSX General Market Disclosure Other - Acquisition of Novel Glucose Biosensor IQN - IQX Subsidiary Acquires Novel Glucose Biosensor |
29-Jun-2016 2:40:21 PM |
IQG |
40920 NSX Notice of Extraordinary Meeting - Notice of Extraordinary General Meeting Notice of Extraordinary General Meeting |
06-Jun-2016 7:18:22 PM |
IQG |
41999 NSX General Market Disclosure Other - Listing of Wholly Owned Subsidiary Update - Listing of Wholly Owned Subsidiary, Clinical Research Corporation |
13-May-2016 9:08:47 AM |
IQG |
40099 NSX Official List Other - Intended Move to ASX Intended Move to ASX |
27-Apr-2016 11:40:33 AM |
IQG |
40315 NSX Placement - Extension of Private Placement Closing Date Extension of Private Placement Closing Date |
07-Apr-2016 5:03:05 PM |
IQGPrice Sensitive |
41999 NSX General Market Disclosure Other - Acquisition of oncology biologic compound Acquisition of oncology biologic compound |
05-Apr-2016 1:01:03 PM |
IQG |
40550 NSX Half Yearly Report Audit Review - Financial Statements 31 December 2015 Financial Statements 31 December 2015 |
15-Mar-2016 3:20:44 PM |
IQG |
41999 NSX General Market Disclosure Other - Application for Quotation of Additional Securities Application for Quotation of Additional Securities arising from issues under Employee Share Scheme |
18-Dec-2015 10:21:28 AM |
IQG |
40120 NSX Change in Substantial Shareholder - Change in Substantial Shareholder Interests Change in Substantial Shareholder Interests |
18-Dec-2015 10:10:19 AM |
IQG |
40150 NSX Section 205G Notice Change in Director's Interests - Change of Director's Interests Change of Director's Interests |
18-Dec-2015 10:09:25 AM |
IQG |
40150 NSX Section 205G Notice Change in Director's Interests - Change of Director's Interests Change of Director's Interests |
18-Dec-2015 10:08:17 AM |
IQG |
40930 NSX Results of Meeting - Results of 2015 Annual General Meeting Results of 2015 Annual General Meeting |
17-Nov-2015 7:58:03 PM |
IQG |
41999 NSX General Market Disclosure Other - Amended Announcement – Iqnovate Ltd To Acquire Stake I Amended Announcement – Iqnovate Ltd To Acquire Stake In Creative Agency |
17-Nov-2015 10:50:20 AM |
IQG |
41999 NSX General Market Disclosure Other - iQN Announcement of Emedia aquisition iQN Announcement of Emedia aquisition |
17-Nov-2015 10:16:29 AM |
IQG |
40910 NSX Notice of Annual General Meeting - Notice of Annual General Meeting Notice of Annual General Meeting |
28-Oct-2015 7:43:07 AM |
IQG |
40315 NSX Placement - Extension of Private Placement Closing Date Extension of Private Placement Closing Date |
09-Oct-2015 2:15:10 PM |
IQGPrice Sensitive |
40510 NSX Annual Report - iQnovate Ltd 2015 Annual Report iQnovate Ltd 2015 Annual Report |
11-Sep-2015 3:45:01 PM |
IQG |
41999 NSX General Market Disclosure Other - Closure of GXG Markets Closure of GXG Markets |
18-Aug-2015 3:42:50 PM |
IQG |
41999 NSX General Market Disclosure Other - Update - Nasdaq cross-listing Update - Nasdaq cross-listing |
14-Aug-2015 2:21:49 PM |
IQG |
41999 NSX General Market Disclosure Other - Listing of Wholly Owned Subsidiary Listing of Wholly Owned Subsidiary |
22-May-2015 9:20:20 AM |
IQG |
40750 NSX Details of Share Registry - Change of Registry Address Change of Registry Address |
15-May-2015 4:40:41 PM |
IQGPrice Sensitive |
40540 NSX Half Yearly Report - iQnovate Ltd Half Yearly Report - 31 Dec 14 iQnovate Ltd Half Yearly Report for the Period Ended 31st December 2014 |
13-Mar-2015 8:03:02 PM |
IQG |
41999 NSX General Market Disclosure Other - Private Placement of the Company’s Shares Private Placement of the Company’s Shares |
13-Mar-2015 8:53:14 AM |
IQG |
41999 NSX General Market Disclosure Other - Listing of Wholly Owned Subsidiary Listing of Wholly Owned Subsidiary |
11-Mar-2015 10:53:29 AM |
IQG |
41999 NSX General Market Disclosure Other - NASDAQ Cross-listing NASDAQ Cross-listing |
05-Mar-2015 5:05:18 PM |
IQG |
41999 NSX General Market Disclosure Other - Upgrade to OTCQB Marketplace Upgrade to OTCQB Marketplace |
26-Feb-2015 3:57:33 PM |
IQG |
41999 NSX General Market Disclosure Other - Application for quotation of securities Application for quotation of securities |
23-Dec-2014 5:02:13 PM |
IQG |
40380 NSX Exercise of Options - Exercise of Options Exercise of Options |
23-Dec-2014 12:33:51 PM |
IQG |
40140 NSX Section 205G Notice Initial/Final Director's Interests - Notice of Final Director's Interests Notice of Final Director's Interests |
02-Dec-2014 9:19:50 AM |
IQG |
40810 NSX Director Appointment/Resignation - Director Retirement Director Retirement |
02-Dec-2014 9:18:33 AM |
IQG |
40930 NSX Results of Meeting - Results of 2014 AGM Results of 2014 AGM |
02-Dec-2014 9:17:24 AM |
IQG |
40910 NSX Notice of Annual General Meeting - 2014 IQN Notice of Annual General Meeting and Proxy 2014 IQN Notice of Annual General Meeting and Proxy |
29-Oct-2014 9:47:32 PM |
IQGPrice Sensitive |
40510 NSX Annual Report - 2014 Annual Report 2014 Annual Report |
12-Sep-2014 3:30:31 PM |
IQG |
40320 NSX Issues to Public - Application for Quotation of Additional Securities - Exercise of Options Application for Quotation of Additional Securities - Exercise of Options |
22-Aug-2014 9:59:11 AM |
IQG |
40380 NSX Exercise of Options - Exercise of Options Options to acquire 4,000,000 shares are due for expiry in December 2014 exercisable at 10c a share. Notices of Exercise of Options have been received to date for 3,200,000 shares. |
21-Aug-2014 9:33:47 AM |
IQG |
40599 NSX Periodic Disclosure Other - Nominated Advisers Annual Statement to NSX Nominated Advisers Annual Statement to NSX |
18-Aug-2014 1:22:57 PM |
IQG |
40814 NSX Company Secretary Appointment/Resignation - Change of Company Secretary Change of Company Secretary from Mr Spiro Sakiris to Mr Kelvin Boateng |
24-Jul-2014 3:13:12 PM |
IQG |
40320 NSX Issues to Public - Application for Quotation of Exercised Options Application for Quotation of Exercised Options |
18-Jun-2014 4:40:49 PM |
IQG |
41999 NSX General Market Disclosure Other - Excercise of Options Recent Activity in Exercise of Company Options |
17-Jun-2014 9:04:45 AM |
IQG |
41999 NSX General Market Disclosure Other - Capital Raise Subsidiaries to raise capital - 708 Corporations Act |
02-May-2014 4:22:26 PM |
IQGPrice Sensitive |
40540 NSX Half Yearly Report - Half Yearly Financial Report Financial Statements for 6 months ending 31st December 2013 |
14-Mar-2014 2:22:15 PM |
IQG |
40380 NSX Exercise of Options - Application for Quotation of Exercised Options Application for Quotation of Exercised Options |
20-Jan-2014 3:28:53 PM |
IQG |
41999 NSX General Market Disclosure Other - Application for Quotation of Additional Securities Application for Quotation of Additional Securities Arising from Expiry of Escrow & Options |
20-Dec-2013 10:42:06 AM |
IQG |
41999 NSX General Market Disclosure Other - Excercise of Options Results of Excercise of Options |
19-Dec-2013 2:01:07 PM |
IQG |
40930 NSX Results of Meeting - Results from 2013 AGM Results from 2013 Annual General Meeting |
03-Dec-2013 2:55:34 PM |
IQG |
41999 NSX General Market Disclosure Other - Addendum to 2013 Annual Report Addendum to page 9 of 2013 Annual Report |
19-Nov-2013 2:33:20 PM |
IQG |
40940 NSX Proxy Form - 2013 AGM Proxy Form 2013 AGM Proxy Form |
01-Nov-2013 9:13:33 AM |
IQG |
41999 NSX General Market Disclosure Other - Addendum to 2013 Annual Report Addendum to 2013 Annual Report lodged 27th September 2013 |
27-Oct-2013 7:29:57 AM |
IQG |
40910 NSX Notice of Annual General Meeting - Notice of 2013 Annual General Meeting Notice of 2013 Annual General Meeting |
26-Oct-2013 12:10:13 PM |
IQGPrice Sensitive |
40510 NSX Annual Report 2013 Annual Report / Statutory Financial Statements as Required by s319 Corporations Act |
27-Sep-2013 5:00:14 PM |
IQGPrice Sensitive |
40530 NSX Preliminary/Final Statement - Preliminary Final Report Preliminary Final Report for the year ended 30th June 2013 |
13-Sep-2013 6:01:52 AM |
IQG |
41999 NSX General Market Disclosure Other - Approval to Commence Trading on GXG IQNovate unanimously approved by the GXG Admissions Committee, to commence trading on the Main Quote of GXG. |
12-Sep-2013 2:03:38 PM |
IQG |
40599 NSX Periodic Disclosure Other - Nominated Advisers Annual Statement to NSX Nominated Advisers Annual Statement to NSX |
27-Aug-2013 12:21:40 PM |
IQG |
41999 NSX General Market Disclosure Other - Listing on GXG Europe Listing on Main Quote of GXG - The European Exchange for SME's |
01-Aug-2013 10:09:53 AM |
IQG |
41999 NSX General Market Disclosure Other - IQNovate ADRs Piggyback Qualified in the USA USA Investors will haveaccess to IQNovate ADRs |
14-Jun-2013 8:56:24 AM |
IQG |
40081 NSX Response to Query - Response to Price Query - trade executed 5th of June 2013
Response to Price Query - trade executed 5th of June 2013 |
07-Jun-2013 10:29:03 AM |
IQG |
40080 NSX Query - Price Query - trades executed on the 5th of June 2013
Price Query - trades executed on the 5th of June 2013 |
07-Jun-2013 10:25:43 AM |
IQG |
40081 NSX Response to Query - Response to Price Query - trade executed 4th of June 2013 Response to Price Query - trade executed 4th of June 2013 |
05-Jun-2013 10:26:05 AM |
IQG |
40080 NSX Query - Price Query - trade executed on the 4th of June 2013 Price Query - trade executed on the 4th of June 2013 |
05-Jun-2013 10:25:38 AM |
IQG |
41999 NSX General Market Disclosure Other - US Media Coverage US Media Coverage Further to Quotation Clearance |
23-May-2013 9:01:52 PM |
IQG |
41999 NSX General Market Disclosure Other - IQNovate Ltd Receives Quotation Clearance for OTC Pink IQnovate receives quotation clearance for its Level 1 ADRs on OTC Pink in the USA |
13-May-2013 9:28:33 AM |
IQG |
40816 NSX Nominated Adviser Appointment/Resignation - Change of Nominated Advisor IQ3 Corp Ltd Appointed as Nominated Advisor |
22-Mar-2013 10:25:46 AM |
IQG |
40540 NSX Half Yearly Report - Half Yearly Financial Statements - 31 December 2012 Half Yearly Financial Statements - 31 December 2012 |
15-Mar-2013 10:22:59 AM |
IQG |
40320 NSX Issues to Public - Private Placement Issue and Release of 1 year Escrow Private Placement Issue and Release of 1 year Escrow Shares |
13-Mar-2013 3:28:54 PM |
IQG |
40315 NSX Placement - Closure of Private Placement Closure of Private Placement |
12-Mar-2013 12:49:03 PM |
IQG |
41999 NSX General Market Disclosure Other - IQNovate Ltd included in Mergent's manual in the USA Mergent’s Editorial Board has approved IQNovate for a listing in Mergent Manuals and News Reports™. |
18-Dec-2012 7:36:21 PM |
IQG |
41999 NSX General Market Disclosure Other - IQN Begins Trading in US thorugh Launch of ADRS IQN Begins Trading in US thorugh Launch of ADRS |
17-Dec-2012 10:39:09 AM |
IQG |
40022 NSX Articles of Association/Constitution - Updated Constitution Copy of updated Constitution passed at the company's AGM dated 29th November 2012 |
07-Dec-2012 11:04:37 AM |
IQG |
40930 NSX Results of Meeting - Results of 2012 AGM Results of Resolutions Passed at 2012 AGM |
30-Nov-2012 3:40:50 PM |
IQG |
40150 NSX Section 205G Notice Change in Director's Interests - Change in Director's Interests - G Syrmalis Change in Director's Interests - G Syrmalis |
29-Nov-2012 9:51:37 AM |
IQG |
40150 NSX Section 205G Notice Change in Director's Interests - Change in Director's Interests - G Syrmalis Change in Director's Interests - G Syrmalis |
28-Nov-2012 10:17:45 AM |
IQG |
40081 NSX Response to Query - Response from Issuer to Price Query dated 20th of November 2012 Response from Issuer to Price Query dated 20th of November 2012 |
22-Nov-2012 12:45:58 PM |
IQG |
40080 NSX Query - Price Query for trades executed on the 20th of November 2012 Price Query for trades executed on the 20th of November 2012 |
22-Nov-2012 12:43:48 PM |
IQG |
41999 NSX General Market Disclosure Other - IQNovate to undertake private share placement IQNovate to undertake private share placement in the coming weeks |
30-Oct-2012 1:06:23 PM |
IQG |
40510 NSX Annual Report - 2012 IQNovate Ltd Annual Report 2012 IQNovate Ltd Annual Report |
29-Oct-2012 12:16:02 PM |
IQG |
40910 NSX Notice of Annual General Meeting - Notice of 2012 Annual General Meeting Notice of 2012 Annual General Meeting including attachments |
29-Oct-2012 12:15:32 PM |
IQGPrice Sensitive |
41999 NSX General Market Disclosure Other - IQNovate signs agreement with Connect Biotech Pvte Ltd in India IQNovate signs Heads of Agreement with Connect Biotech Pvte Ltd in India to identify suitable business entities for potential acquisition |
29-Oct-2012 11:58:10 AM |
IQG |
40051 NSX Reinstatement to Official Quotation - Removal of requested trading halt. Removal of requested trading halt. |
03-Oct-2012 10:14:30 AM |
IQGPrice Sensitive |
41999 NSX General Market Disclosure Other - Iqnovate seeking to list on OTC Pink Marketplace in USA The company is seeking to list instruments on the OTC Pink Marketplace in the USA |
03-Oct-2012 10:07:52 AM |
IQGPrice Sensitive |
41999 NSX General Market Disclosure Other - Withdrawal of Application for Listing on ASX Company decides to withdraw application to list on ASX |
03-Oct-2012 9:58:35 AM |
IQGPrice Sensitive |
40030 NSX Trading Halt - Iqnovate Ltd Requests Trading Halt Iqnovate Ltd requests up to 24hr trading halt pending announcement |
02-Oct-2012 1:26:25 PM |
IQGPrice Sensitive |
40530 NSX Preliminary/Final Statement - Statutory Financial Accounts as required by Corporations Act Statutory Financial Accounts For The Year Ending 30th June 2012 |
28-Sep-2012 6:28:36 AM |
IQG |
40081 NSX Response to Query - Response to Price Query - 13th of September 2012 Response to Price Query - 13th of September 2012 |
17-Sep-2012 3:02:38 PM |
IQG |
40080 NSX Query - Price query for trade executed from 13th of September 2012 Price query for trade executed from 13th of September 2012 |
17-Sep-2012 3:00:57 PM |
IQGPrice Sensitive |
40530 NSX Preliminary/Final Statement - Prelinimary Final Report - 30 June 2012 Prelinimary Final Report - 30 June 2012 |
14-Sep-2012 8:33:51 AM |
IQG |
40599 NSX Periodic Disclosure Other - Nominated Advisers Annual Statement to NSX Nominated Advisers Annual Statement to NSX |
13-Aug-2012 10:20:28 AM |
IQG |
41999 NSX General Market Disclosure Other - Update on Move To ASX General Update on Migration To ASX |
03-Aug-2012 3:27:32 PM |
IQG |
40930 NSX Results of Meeting - Passing of Resolution at Extraordinary General Meeting The shareholders of the Company passed a resolution to amend to Constitution of the Company to comply with the ASX listing rules |
26-Jun-2012 1:30:09 PM |
IQG |
40460 NSX Agreement Notice - IQNovate Limited Signs Technical Services Agreement IQNovate has entered into an agreement for technical services and support for the assessment, identification, analysis and due diligence investigation of potential investments. |
14-Jun-2012 1:07:16 PM |
IQG |
40920 NSX Notice of Extraordinary Meeting - Notice of Extraordinary General Meeting To consider and if thought fit pass a resolution to approve minor changes to the constitution of the Company to ensure that the Company constitution meets the requirements of the ASX as well as the NSX. |
14-May-2012 3:08:53 PM |
IQGPrice Sensitive |
40460 NSX Agreement Notice - IQnovate Signs Memorandum of Understanding with
Nanosonics Contract medical group IQnovate Limited (NSX: IQN) announced today it had signed a Memorandum of Understanding with the Australian medical device company, Nanosonics Limited. |
02-May-2012 1:12:36 PM |
IQG |
40315 NSX Placement - Share placement A total of 749,390 shares were issued at $0.88c on 24 April 2012 (640,072 shares) and 2 May 2012 (109,318 shares). |
02-May-2012 12:57:47 PM |
IQGPrice Sensitive |
41999 NSX General Market Disclosure Other - IQnovate Seeks to Move to ASX IQnovate announces that it will seek to move to the ASX |
30-Mar-2012 12:12:27 PM |
IQGPrice Sensitive |
40315 NSX Placement - IQnovate Share Placement Completion IQnovate announces completion of share placement commenced on 8th March |
30-Mar-2012 10:51:00 AM |
IQGPrice Sensitive |
40460 NSX Agreement Notice - IQnovate Signs Memorandum of Understanding IQnovate Signs Memorandum of Understanding with JH Biotech Australasia Pty Ltd |
14-Mar-2012 4:21:52 PM |
IQGPrice Sensitive |
40540 NSX Half Yearly Report - Half Year Report Iqnovate Ltd Half Year Report for months ending 31st December 2012 |
13-Mar-2012 3:00:28 PM |
IQGPrice Sensitive |
40315 NSX Placement - IQnovate to Undertake Share Placement IQnovate to Undertake Share Placement |
08-Mar-2012 4:47:13 PM |
IQG |
41999 NSX General Market Disclosure Other - Appointment of Business Development Manager and Move of Headquarters to CBD IQnovate Ltd announces appointment of Ms Janine Horton as Business Development Manager, and the move of the company's corporate headquarters to Sydney CBD. |
22-Feb-2012 3:48:35 PM |
IQG |
40150 NSX Section 205G Notice Change in Director's Interests - Change in Director's Interests - C Tisgounis Change in Director's Interests - C Tisgounis |
30-Jan-2012 2:48:10 PM |
IQG |
40081 NSX Response to Query - Response to Price Query. Response to Price Query. |
27-Jan-2012 1:17:21 PM |
IQG |
40080 NSX Query - Price query for trade executed from 17th of Jan to 23rd of Jan 2012 Price query for trade executed from 17th of Jan to 23rd of Jan 2012 |
27-Jan-2012 1:17:03 PM |
IQG |
41999 NSX General Market Disclosure Other - Shares in World's First Contract Medical Company Soar on Listing Shares in World's First Contract Medical Company Soar on Listing |
15-Dec-2011 12:28:09 PM |
IQG |
40020 NSX Commencement of Official Quotation - Commencement of Quotation - 15th of December 2011 Commencement of Quotation - 15th of December 2011 |
14-Dec-2011 10:44:33 AM |
IQG |
40025 NSX Sponsor's Declaration - Sponsoring Broker's Declaration Sponsoring Broker's Declaration |
14-Dec-2011 10:28:02 AM |
IQG |
40023 NSX Director's Declaration & Undertaking - Director's Declaration & Undertaking - William Economos Director's Declaration & Undertaking - William Economos |
14-Dec-2011 10:27:41 AM |
IQG |
40023 NSX Director's Declaration & Undertaking - Director's Declaration & Undertaking - George Syrmalis Director's Declaration & Undertaking - George Syrmalis |
14-Dec-2011 10:27:12 AM |
IQG |
40023 NSX Director's Declaration & Undertaking - Director's Declaration & Undertaking - Con Tsigounis Director's Declaration & Undertaking - Con Tsigounis |
14-Dec-2011 10:26:51 AM |
IQG |
40023 NSX Director's Declaration & Undertaking - Director's Declaration & Undertaking - Peter Simpson Director's Declaration & Undertaking - Peter Simpson |
14-Dec-2011 10:26:13 AM |
IQG |
40099 NSX Official List Other - Issuers Undertaking Issuers Undertaking |
14-Dec-2011 10:24:44 AM |
IQG |
40024 NSX Nominated Adviser's Declaration - Nominated Adviser's Declaration Nominated Adviser's Declaration |
14-Dec-2011 10:24:26 AM |
IQG |
40520 NSX Top 20 Shareholders - Top 20 & Shareholder Spread Top 20 & Shareholder Spread |
14-Dec-2011 10:24:07 AM |
IQG |
40022 NSX Articles of Association/Constitution - Company Constitution Company Constitution |
14-Dec-2011 10:23:46 AM |
IQG |
40350 NSX Prospectus - Company Prospectus Company Prospectus |
14-Dec-2011 10:23:03 AM |
IQG |
40010 NSX Admission to Official List - Letter of Application Letter of Application |
14-Dec-2011 10:22:46 AM |
IQG |
40350 NSX Prospectus - Extension of offer Extension of offer |
18-Nov-2011 3:55:28 PM |
IQG |
40350 NSX Prospectus - Prospectus Prospectus |
19-Sep-2011 12:28:44 PM |